Table 1

Demographic and baseline characteristics and incidence of thromboembolism (TE) associated with each variable in univariate analysis

VariableAll patients (n=500)TE (+), n=70TE (−), n=430P values*
No. of patientsNo. of patients (%)No. of patients (%)
Age, years
 Median69.066.169.60.568
 Range21.1–89.127.1–89.121.1–89.0
Sex
 Female19420 (10.3)174 (89.7)0.058
 Male30650 (16.3)256 (83.7)
ECOG PS
 0–144967 (14.9)382 (85.1)0.078
 ≥2513 (5.9)48 (94.1)
Cancer type
 Gastric cancer20619 (9.2)187 (90.8)0.010
 Colorectal cancer29451 (17.3)243 (82.7)
Histological subtype
 Well and Mod31749 (15.5)268 (84.5)0.365
 Others16921 (12.4)148 (87.6)
 Unknown140 (0)14 (100.0)
Resection of primary site
 No12218 (14.8)104 (85.2)0.782
 Yes37852 (13.8)326 (86.2)
Adj or non-Adj setting
 Non-Adj30654 (17.6)252 (82.4)0.003
 Adj19416 (8.2)178 (91.8)
Patients with active cancer (AC)
 Non-AC1415 (3.5)136 (96.5)<0.0001
 AC35965 (18.1)294 (81.9)
Single or multiple primary
 Single45058 (12.9)392 (87.1)0.032
 Multiple5012 (24.0)38 (76.0)
Khorana score
 High889 (10.2)79 (89.8)0.254
 Intermediate21828 (12.8)190 (87.2)
 Low19433 (17.0)161 (83.0)
 CVC placement
 No16814 (8.3)154 (91.7)0.009
 Yes33256 (16.8)276 (83.1)
  • *P values: Mann-Whitney U test or χ2 test.

  • Adj, adjuvant; CVC, central venous catheter; Mod, moderately differentiated adenocarcinoma; ECOG PS, Eastern Cooperative Oncology Group Performance Status; Well, well-differentiated adenocarcinoma.